Peritonsillar abscess assessment tool.

IF 1.2 4区医学 Q3 MEDICINE, GENERAL & INTERNAL Danish medical journal Pub Date : 2024-07-17 DOI:10.61409/A01240060

Ann Marlene Gram Kjærulff, Simon Fuglsang, Tejs Ehlers Klug

{"title":"Peritonsillar abscess assessment tool.","authors":"Ann Marlene Gram Kjærulff, Simon Fuglsang, Tejs Ehlers Klug","doi":"10.61409/A01240060","DOIUrl":null,"url":null,"abstract":"Introduction: We developed and validated a patient-reported outcome measurement for measuring the severity of symptoms and efficacy of different treatment modalities in patients with peritonsillar abscess (PTA).Methods: A 19-item questionnaire was constructed using a five-point Likert scale. Fifteen to 40-year-old patients with PTA treated at two ear-nose-throat departments completed the survey. Healthy students served as controls.Results: A total of 51 PTA patients and 76 controls were included. Twelve items had appropriate inter-item correlations (in the 0.25-0.75 range) and high mean scores (> 3.5) among patients and were therefore included in the final tool, coined the peritonsillar abscess assessment tool (PAAT)-12. The patients' mean PAAT-12 score was 49.0 (95% confidence interval (CI): 46.8-51.1) at the time of inclusion compared with 14.2 (95% CI: 13.7-14.7) for controls (p less-than 0.001). The Cronbach's alpha coefficient for the questionnaire was 0.86. The standard error of measurement was 4.98, the intraclass correlation 0.88 and the Spearman correlation test-retest reliability 0.79.Conclusion: The reliability and validity of the PAAT-12 were very high. The PAAT-12 is the first validated tool for measuring the severity and duration of symptoms from the perspective of PTA patients and for quantifying and comparing different treatment modalities in PTA patients.Funding: Overlærer Svend Hansens Fond.Trial registration: The study was approved by the Danish Data Protection Agency (#1-16-02-356-19).","PeriodicalId":11119,"journal":{"name":"Danish medical journal","volume":"71 8","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Danish medical journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.61409/A01240060","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: We developed and validated a patient-reported outcome measurement for measuring the severity of symptoms and efficacy of different treatment modalities in patients with peritonsillar abscess (PTA).

Methods: A 19-item questionnaire was constructed using a five-point Likert scale. Fifteen to 40-year-old patients with PTA treated at two ear-nose-throat departments completed the survey. Healthy students served as controls.

Results: A total of 51 PTA patients and 76 controls were included. Twelve items had appropriate inter-item correlations (in the 0.25-0.75 range) and high mean scores (> 3.5) among patients and were therefore included in the final tool, coined the peritonsillar abscess assessment tool (PAAT)-12. The patients' mean PAAT-12 score was 49.0 (95% confidence interval (CI): 46.8-51.1) at the time of inclusion compared with 14.2 (95% CI: 13.7-14.7) for controls (p less-than 0.001). The Cronbach's alpha coefficient for the questionnaire was 0.86. The standard error of measurement was 4.98, the intraclass correlation 0.88 and the Spearman correlation test-retest reliability 0.79.

Conclusion: The reliability and validity of the PAAT-12 were very high. The PAAT-12 is the first validated tool for measuring the severity and duration of symptoms from the perspective of PTA patients and for quantifying and comparing different treatment modalities in PTA patients.

Funding: Overlærer Svend Hansens Fond.

Trial registration: The study was approved by the Danish Data Protection Agency (#1-16-02-356-19).

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

扁桃体周围脓肿评估工具。

简介：我们开发并验证了一种患者报告的结果测量方法，用于测量腹膜周围脓肿（PTA）患者的症状严重程度和不同治疗方式的疗效。方法：采用李克特五分制编制问卷，共19项。15 - 40岁在两个耳鼻喉科接受PTA治疗的患者完成了调查。健康学生作为对照。结果：共纳入51例PTA患者和76例对照组。12个项目在患者中具有适当的项目间相关性（在0.25-0.75范围内）和较高的平均得分（> 3.5），因此被纳入最终工具，创造了腹膜周围脓肿评估工具(PAAT)-12。纳入时患者PAAT-12平均评分为49.0(95%可信区间（CI）： 46.8-51.1)，对照组为14.2 (95% CI: 13.7-14.7) （p < 0.001）。问卷的Cronbach's alpha系数为0.86。计量标准误差为4.98，类内相关0.88，Spearman相关重测信度0.79。结论：PAAT-12具有较高的信度和效度。PAAT-12是从PTA患者角度衡量症状严重程度和持续时间的第一个经过验证的工具，用于量化和比较PTA患者的不同治疗方式。资助：overæ rer send hansen Fond。试验注册：该研究已获得丹麦数据保护局批准（#1-16-02-356-19）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Danish medical journal MEDICINE, GENERAL & INTERNAL-

CiteScore

2.30

自引率

6.20%

发文量

审稿时长

3-8 weeks

期刊介绍： The Danish Medical Journal (DMJ) is a general medical journal. The journal publish original research in English – conducted in or in relation to the Danish health-care system. When writing for the Danish Medical Journal please remember target audience which is the general reader. This means that the research area should be relevant to many readers and the paper should be presented in a way that most readers will understand the content. DMJ will publish the following articles: • Original articles • Protocol articles from large randomized clinical trials • Systematic reviews and meta-analyses • PhD theses from Danish faculties of health sciences • DMSc theses from Danish faculties of health sciences.

期刊最新文献

Colorectal cancer in Greenland. Danish cross-cultural adaptation of the Theoretical Framework of Acceptability questionnaire. Clinical work perception and mental health in Danish resident doctors. Acute haemodynamic and diuretic effects of intravenous furosemide in acute heart failure. Clinical Frailty Scale scores of older patients admitted to an emergency department.